STOCK

Advertisement
Dec 20 2024BUSINESS

Novo Nordisk's New Weight-Loss Drug Fails to Impress Investors

Novo Nordisk, a big player in Europe's pharma scene, saw its shares take a huge hit on Friday. Why? Their latest weight-loss drug, CagriSema, didn't meet expectations. The drug helped patients lose about 22. 7% of their body weight in late-stage trials, but that was barely better than Eli Lilly's ri

reading time less than a minute
Dec 20 2024FINANCE

Market Moves: Tech Wins, Micron Drops After Fed Sell-Off

Early Thursday, Dow Jones futures signaled a small bounce after a tough market sell-off spurred by the Federal Reserve's rate outlook. While Micron Technology struggled with weak guidance, Nvidia and Tesla started to recover. The Bank of Japan and Bank of England announced rate decisions, with the y

reading time less than a minute
Dec 20 2024HEALTH

Brucellosis Among South Sudan's Pastoralists: A Hidden Threat

Brucellosis is a big deal for people and animals in South Sudan. It's a disease that can make you really sick and cost a lot of money. Not many studies have looked into how common it is there. A recent study checked the blood of pastoralists (people who take care of livestock) and their animals in

reading time less than a minute
Dec 19 2024FINANCE

Markets Shudder: Rate Cuts, Tech Troubles, and a Sudden Drop

On Wednesday, the market took a tumble with the Dow Jones losing over 1, 100 points. Surprisingly, this happened after the Federal Reserve announced plans to cut interest rates twice more in 2025. The S&P 500 and Russell 2000 also suffered significant losses, falling below important thresholds. Trea

reading time less than a minute
Dec 19 2024FINANCE

Why Did Micron's Stock Take a Big Dive?

Micron Technology, a top memory-chip maker, had a rough night after announcing their latest earnings. While they hit close to what experts predicted for the first quarter, their forecast for the next quarter didn't impress investors. This caused Micron's stock to drop dramatically in after-hours tra

reading time less than a minute
Dec 19 2024BUSINESS

Palantir's AI Prowess: From Defense to Prayer Apps, Stock Takes a Dive

Palantir, known for its AI capabilities, saw its stock dip after a brief rally. The company, heavily involved in the defense industry, snagged a $401 million contract extension from the Army for its AI-powered Army Vantage platform. Analysts believe this contract could be worth up to $619 million.

reading time less than a minute
Dec 17 2024FINANCE

Will Tech Stocks Drive the Market to New Heights in 2025?

Mary Ann Bartels, the chief investment strategist at Sanctuary Wealth, has a compelling vision for the S&P 500 in 2025. She predicts the broad market index could surge more than 20%, reaching between 7, 200 and 7, 400 points. This forecast is about 22% higher than the S&P 500's closing on Monday. Ba

reading time less than a minute
Dec 16 2024BUSINESS

Expert Views: Should You Invest in Microsoft (MSFT) and First Solar (FSLR)?

Tech companies are in the spotlight today as analysts share their thoughts on Microsoft (MSFT) and First Solar (FSLR). Deciding which stocks to pick and how to maximize your portfolio can be tricky. Let's break down what the experts are saying. Gil Luria, a top-rated analyst from D. A. Davidson, ha

reading time less than a minute
Dec 16 2024BUSINESS

Tesla's China Demand Soars, Analysts Bullish on Stock

Tesla is seeing a surge in vehicle insurance registrations in China, which is a good sign for demand in this key electric vehicle (EV) market. The company's registrations jumped 17% last week, making it one of the best weeks ever for Tesla. This comes as China's demand for Tesla vehicles continues t

reading time less than a minute
Dec 16 2024BUSINESS

7 Stocks Set to Soar in the Coming Year

Investors always want to boost their portfolios. One smart way to do this is by looking at forecasts for the coming year. This year, we're not focusing on the usual big names like Meta, Amazon, or Tesla. Instead, let's shine a light on seven smaller, but promising stocks. TG Therapeutics (TGTX) is

reading time less than a minute